EDITORIAL
Intravitreal Avastin
Intravitreal Avastin for choroidal neovascularisation in pathological myopia: the controversy continues
Correspondence to:
Correspondence to:
P J Rosenfeld
Bascom Palmer Eye Institute, University of Miami School of Medicine, 900 NW 17th Street, Miami, FL 33136, USA; prosenfeld@med.miami.edu
Intravitreal Avastin provides an opportunity to prevent visual acuity loss particularly in non-Western countries
| The first 150 words of the full text of this article appear below. |
In this issue, Yamamoto et al1 and Sakaguchi et al2(see page 157 and page 161) are the first to report the use of intravitreal Avastin (bevacizumab; Genentech, Roche) for the treatment of subfoveal choroidal neovascularisation (CNV) secondary to pathological myopia. The use of intravitreal Avastin in this disease is a natural extension of the previous work with intravitreal Avastin in neovascular age related macular degeneration (AMD). Last year, Michels et al3 reported on systemic Avastin for the treatment of neovascular AMD in nine patients followed over 3 months, and this cohort was subsequently expanded to 18 patients followed over 6 months.4 During these 6 months, the authors observed a rapid and sustained improvement in visual acuity and anatomical outcomes. Following the report of these initial observations, a much smaller dose of Avastin was injected intravitreally in a patient with CNV from AMD and a patient with
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
Relevant Articles
- Intravitreal bevacizumab (Avastin) as treatment for subfoveal choroidal neovascularisation secondary to pathological myopia
- Izumi Yamamoto, Adam H Rogers, Elias Reichel, Paul A Yates, and Jay S Duker
Br. J. Ophthalmol. 2007 91: 157-160.[Abstract] [Full Text] [PDF]
- Intravitreal injection of bevacizumab for choroidal neovascularisation associated with pathological myopia
- H Sakaguchi, Y Ikuno, F Gomi, M Kamei, M Sawa, M Tsujikawa, Y Oshima, S Kusaka, and Y Tano
Br. J. Ophthalmol. 2007 91: 161-165.[Abstract] [Full Text] [PDF]
This article has been cited by other articles:
-
Wong, D., Li, K. K W
(2008). Avastin in myopic choroidal neovascularisation: is age the limit?. Br. J. Ophthalmol.
92: 1011-1012
[Full Text] -
Arias, L, Planas, N, Prades, S, Caminal, J M, Rubio, M, Pujol, O, Roca, G
(2008). Intravitreal bevacizumab (Avastin) for choroidal neovascularisation secondary to pathological myopia: 6-month results. Br. J. Ophthalmol.
92: 1035-1039
[Abstract] [Full Text]
- Full Text
- Full Text (PDF)
- Submit a response
- Alert me when this article is cited
- Alert me when eLetters are posted
- Alert me if a correction is posted
- Citation Map
Services
- Email this link to a friend
- Similar articles in this journal
- Similar articles in PubMed
- Add article to my folders
- Download to citation manager
- Request Permissions
Citing Articles
Google Scholar
PubMed
Topic Collections
Bookmark with
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
